Kangmei Pharmaceutical Co., Ltd. (SHA:600518)

Kangmei Pharmaceutical Revenue

Kangmei Pharmaceutical had revenue of 1.21B CNY in the quarter ending June 30, 2026, a decrease of -5.27%. This brings the company's revenue in the last twelve months to 4.97B, down -6.18% year-over-year. In the year 2025, Kangmei Pharmaceutical had annual revenue of 5.25B with 1.22% growth.

• Revenue (ttm): 4.97B
• Revenue Growth: -6.18%
• P/S Ratio: 3.93
• Revenue / Employee: 904.10K
• Employees: 5,492
• Market Cap: 19.50B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	5.25B	63.08M	1.22%
Dec 31, 2024	5.19B	315.12M	6.47%
Dec 31, 2023	4.87B	693.87M	16.60%
Dec 31, 2022	4.18B	27.63M	0.67%
Dec 31, 2021	4.15B	-1.26B	-23.27%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 31, 2026

Data Sources Report a data error